Does YI pay a dividend and is it safe?

111 Inc. (YI) offers a 0% cash dividend yield ($0.00 annualized) and 1.8% total shareholder yield including buybacks. Roarable rates its payout coverage as REINVESTING IN GROWTH + BUYBACKS.

Stock Ratings / Consumer Staples / YI / dividends

PETS (19) RDGT (36) GRDN (71) CVS (60) ⌘ Pro Terminal →

111 Inc. (YI) Dividend Safety Gauge & 10-Year DRIP Compounder

$2.92 +2.46% NASDAQ • Live Quote vs Prior Daily Close (Synced Snapshot) EXT / AFTER-HRS: $2.93

111 Inc. (YI) carries a Roarable Rating of D- (Sell) with 37/100 RQD Confidence due to weak cash-flow efficiency and sensitivity to current interest rates. Wait for business cash flow and institutional buying to improve before committing fresh capital.

ROARABLE D- • RED ALERT Cap $25.1M

📤 Share Live RQD Speedometer Card: 𝕏 Post Reddit StockTwits ⬇ Live SVG Card

⚡ INSTANT AI QUANT PREVIEW • $0 FREE TIER Click Any Pre-Computed AI Quant Specialist Briefing on YI Below — or Connect Your Own ChatGPT / Claude

🤖 Mara Quenwick • AI Quant Lead (Click for Instant Brief) Is YI stock a Buy, Hold, or Sell right now according to Roarable's RQD model?

▼

As of 2026-11-03, 111 Inc. (NASDAQ: YI) is rated D- (Sell / SELL) by Roarable's 5-pillar RQD engine with a composite confidence score of 37/100 at a spot price of $2.92 (+2.46% 1D, market cap $25.1M). Pillar breakdown: Fundamental Cash Engine 9/20, Institutional 13F & Options Flow 3/20, SEC Balance-Sheet Forensics 12/20, FRED Macro Regime Fit 8/20, and Executive Insider Alignment 5/20. Across 147 tracked Consumer Staples issuers, YI ranks #113 in composite RQD confidence.

✓ Pre-computed one-to-many AI Quant brief

🤖 Ellis Vennor • AI Peer & Flow Quant (Click for Instant Brief) How does YI compare to PETS and RDGT in the Consumer Staples sector?

▼

Within the Consumer Staples sector (Retail-Drug Stores and Proprietary Stores), YI carries a Roarable D- (37/100 RQD), trailing P/E of N/A, gross margin of 5.8%, and ROIC of -20.5%. By comparison, PETS (PetMed Express Inc.) holds a E grade (19/100 RQD, P/E N/A, ROIC -35.0%, cap $25.8M) and RDGT (Ridgetech Inc.) posts a D- grade (36/100 RQD, P/E N/A, ROIC —, cap $2.9M). Among the 5-stock peer group, GRDN leads on earnings multiple (52.1x) while GRDN leads on capital efficiency (37.7% ROIC).

✓ Pre-computed one-to-many AI Quant brief

🤖 Gideon Ashmere • AI SEC 10-K Forensics (Click for Instant Brief) What are the biggest fundamental strengths and SEC risk factors for YI?

▼

Per YI's SEC EDGAR XBRL 10-K filing (FY2025, filed 2025-12-31, CIK 0001738906), 111 Inc. generated $1.80B in revenue (-9.0% YoY), $0 in net income, and $16.4M in free cash flow against $314.6M in total assets and $0 in total debt. Key quantitative strengths: Established market leader in Consumer Staples with deep daily trading liquidity. Primary risk factors monitored: Company executives have done more routine share selling than personal cash buying lately. Institutional options positioning shows a 50% call / 50% put premium split.

✓ Pre-computed one-to-many AI Quant brief

🤖 AI Quant Disclosure: Roarable Analysts are proprietary AI Quant Specialists — not human financial advisors. Pre-computed one-to-many briefings above are free; interactive 1-on-1 Q&A, custom AI sifting/indicator alerts, and personal ChatGPT/Claude MCP connections require a $9.95/mo Pro account (currently waitlist-only).

INTERACTIVE SCENARIO DECK:

🛡️ Portfolio Crash X-Ray

EXT / AFTER-HRS: $2.93 (+0.25%)🧬 Disciplined Float (+0.72% YoY Shares)⚙️ Cash Engine: 9/20 (D) • 0.9% FCF Margin

Verify 90D Bucket Audit →

📊 Historical Track Record Warning: Scores below 50 (37/100 · D-) historically underperformed SPY in 71% of rolling 90-day windows (-8.1% avg 90D alpha vs SPY • 29.0% hit rate).

Audit Bucket Track Record →

RQD QUANT TACHOMETERRED ALERT • D-

2-of-3 JEV AI Jury Bearish Warning

Cash

SEC

Whale

Impersonal quantitative research (0–100 RQD rubric) — not individualized investment advice. Past performance does not guarantee future results. Full Disclaimer

5-PILLAR SNOWFLAKE RADARRw E · Rk D

Each axis scored 0–20

12M PRICE TARGET CONE-9.6% Base Target

WHALE OPTIONS SNAPSHOT: — (No Active Options Snapshot on file for YI)Realized 20D OHLCV Swing Band: ±9.2%

Deterministic 5-Pillar Attribution (37/100 Composite)

🔍 WHY YI SCORES 37/100 (D-) — TOP 3 DRIVERS2 Bullish Pillars + #1 Risk Drag

▲ #1 Bullish Driver: SEC 10-K Forensic Risk+12/20 pts (32% of score)

Altman Z-Score 3.34 (FORTRESS SAFE (>3.0)) • Piotroski F-Score 3/9

▲ #2 Bullish Driver: Cash Engine Quality+9/20 pts (24% of score)

SEC XBRL FY 2025 (10-K): 0.9% FCF Margin ($16.4M FCF) & 5.8% Gross Margin

▼ #1 Drag / Risk Factor: Whale & Options Positioning4/20 pts (-16 pt drag)

Put hedging (50% put share) caps near-term gamma upside (-16 pts vs max)

📈 PAST 4 QUARTERS RQD vs SUBSEQUENT RETURNQ1 → Q2 → Q3 → Current

Q1 (-3Q)

Grade D$3.10+1% Next Q

Q2 (-2Q)

Grade D$3.13-4.2% Next Q

Q3 (-1Q)

Grade D$3.00-2.7% Next Q

Current

Grade D-$2.92-8.1% Hist 90D α

Trajectory: D (45) → D- (37)Full Audit →

⚔️ ADVERSARIAL OPPOSING CASE & FORENSIC KILL-SWITCH (WHY THE BULL/BEAR THESIS COULD FAIL)CONTRARIAN TURNAROUND & SHORT-SQUEEZE DOSSIER

⚔️ Adversarial Opposing Case: What Could Spark a YI Turnaround Squeeze

Gideon Ashmere Forensic Desk →

While YI currently carries a cautious 37/100 (D-) rating due to Whale & Options Positioning (4/20), shorts face asymmetric squeeze risk if free cash flow inflects or management executes accretive buybacks.

🚀 Contrarian Squeeze Trigger #1

Established market leader in Consumer Staples with deep daily trading liquidity.

🚀 Contrarian Squeeze Trigger #2

Options & Short-Covering Gamma: Reclaiming the 50-day SMA ($3.29) and Max Pain ($3.07) forces dealer call-delta covering toward $11.73.

🚀 Contrarian Squeeze Trigger #3

Forensic Repair Trigger: Halting share dilution (Disciplined Float (+0.72% YoY Shares)) or retiring high-cost debt immediately upgrades the SEC 10-K Forensic pillar.

🎲 LIVE PREDICTION MARKET ODDS TIED TO $YI• $2.4M Crowd Pool • Kalshi / Polymarket Composite

Contract: “YI Beats Next Quarter EPS Consensus (Dec 30, 2026) & Holds Above 200D SMA”

YES 37%NO 63%Trade / Inspect Odds →

CASH DIVIDEND + BUYBACK YIELD

1.8% Total Yield

0% Cash ($0.00/yr) + 1.8% Buybacks

PAYOUT SAFETY SPEEDOMETER

74/100 • REINVESTING IN GROWTH + BUYBACKS

FREE CASH FLOW PAYOUT RATIO

0% (100% Reinvested)

Retains cash flow for R&D and share repurchases

INTERACTIVE DRIP & SHAREHOLDER-YIELD COMPOUNDER (5.5% EST. ANNUAL)

$10,000 Compounded Over 10 Years → $17,081

Est. Year-10 Shareholder Yield: $307/yr

Starting Investment: $10,000

Compounding Horizon: 10 Years

$10.6K

Yr 1

$11.1K

Yr 2

$11.7K

Yr 3

$12.4K

Yr 4

$13.1K

Yr 5

$13.8K

Yr 6

$14.5K

Yr 7

$15.3K

Yr 8

$16.2K

Yr 9

$17.1K

Yr 10

ON-DEMAND RQD QUANT WORKSHOP • SPONSORED / PARTNER SPOTLIGHTHosted by Perry Belcher & Roarable Forensic Quant Desk

Red-Light Warning Desk: Spotting SEC Cash-Flow & Dilution Risks Before Downgrades (Featuring YI)

✓Walkthrough of YI's RQD Radar, SEC cash-conversion gap & downside invalidation levels
✓3 asymmetric Bear/Hedge frameworks when 10-year Treasury yields stay elevated
✓Includes nightly RQD rating-change & forensic signal email alerts on your tracked stocks

RQD INSIDER CLUB WAITLIST$49/YR PLANNED

Want Custom AI PineScript / Python Indicators & Priority Rating-Change Alerts?

Join Founding VIP Waitlist (No Card Required) →$100K Arena

YI // CANDLESTICK & AUTO-TRENDLINE WORKSTATION6M: -50.68%🛡️ HOLDING TREND SUPPORT

2026-11-03O $2.98H $2.98L $2.85C $2.92VOL 21.6K

RES: $4.06SUP: $2.77SMA50: $3.29SMA200: $5.03

PRIMARY-SOURCE FORENSICS, SECOND-ORDER LINKS & AI ANALYST DESK

YI Dilution Monitor, Expectations Hurdle, Butterfly Connections & Policy Exposure

🦋 YI Butterfly Map → + Track YI →

Share Count & Dilution Monitor

Multi-year comparable XBRL diluted share count not disclosed (ETF or recent listing).

Reverse-DCF Expectations Hurdle

8.0%/yr Implied 5Y Growth

vs. -9.0% actual YoY revenue growth (assuming 9.25% cost of equity & 16.5x terminal multiple).

Ellis Vennor Setup Ledger

No active Ellis Vennor swing setup published on YI today. View full Setup Ledger →

🦋 Documented & Second-Order Butterfly Connections Open Graph →

No direct multi-tier Butterfly edges indexed yet for YI. Explore sector supply chains on /butterfly.

AI Analyst Theses, Washington Policy & Company Video

🎬 No recent verified company-specific video clip queued for YI today (we never pad ticker pages with unrelated generic clips). Browse Macro Video Desk →

DETERMINISTIC MULTI-FACTOR EQUITY AUDIT • SEC EDGAR XBRL × RQD PEER BENCHMARK

📊 Quantitative Sector Peer Comparison, SEC Filing Delta & Investment FAQ (YI)

Consumer Staples Rank #113 of 147 ⚔️ PETS vs YI Full Matrix →

1. Head-to-Head Consumer Staples Peer Comparison (YI vs. PETS, RDGT, GRDN, CVS)

Industry: Retail-Drug Stores and Proprietary Stores (5 Tracked Issuers)

Across 147 tracked Consumer Staples securities in the Roarable RQD universe, 111 Inc. (YI) ranks #113 by composite RQD confidence (37/100, grade D-) and #118 by equity capitalization ($25.1M). Within this direct 5-issuer industry benchmark cohort, GRDN leads on earnings valuation at 52.1x trailing P/E, while GRDN leads on capital efficiency and profitability with 37.7% ROIC and 20.2% gross margin. GRDN currently holds the highest overall quantitative score in the immediate peer group at 71/100 (B-) compared with YI at 37/100 (D-).

Ticker / Company	Roarable Grade	RQD Score	Trailing P/E	Gross Margin	ROIC	1D Change	Market Cap	Head-to-Head
YI ACTIVE 111 Inc.	D-	37/100	—	5.8%	-20.5%	+2.46%	$25.1M	Benchmark Subject
PETS PetMed Express Inc.	E	19/100	—	28.1%	-35.0%	+0.84%	$25.8M	/pets-vs-yi →
RDGT Ridgetech Inc.	D-	36/100	—	3.6%	—	+0.88%	$2.9M	/rdgt-vs-yi →
GRDN Guardian Pharmacy Services Inc. (Class A)	B-	71/100	52.1x	20.2%	37.7%	-1.70%	$2.58B	/grdn-vs-yi →
CVS CVS Health Corporation	C-	60/100	65.3x	45.0%	2.6%	-1.93%	$115.43B	/cvs-vs-yi →

2. Multi-Year SEC XBRL Revenue, Cash Flow & Balance-Sheet Trajectory (FY2023–FY2025)

SEC EDGAR 10-K • FILED 2025-12-31 • CIK 0001738906 ↗

In its most recent audited fiscal period (FY2025, filed 2025-12-31), 111 Inc. (YI) reported GAAP revenue of $1.80B (-9.0% vs. FY2024 revenue of $1.97B , and -14.7% cumulative change since FY2023) , GAAP net income of $0, operating cash flow of $17.0M, and free cash flow of $16.4M (-51.7% YoY). On the balance sheet, YI closed FY2025 with $314.6M in total assets against $0 in total debt (Altman Z-Score: 3.34, Piotroski F-Score: 3/9).

Fiscal Period	Filing Date	Revenue	Net Income	Operating Cash Flow	Free Cash Flow	Total Assets	Total Debt
FY2025 (FY)	2025-12-31	$1.80B	$0	$17.0M	$16.4M	$314.6M	—
FY2024 (FY)	2024-12-31	$1.97B	$0	$36.0M	$34.0M	$381.9M	—
FY2023 (FY)	2023-12-31	$2.11B	$0	-$63.0M	-$63.0M	—	—

3. YI Data-Verified Investor FAQ (RQD Rating, Sector Peers, SEC Forensics & Technicals)

✓ SCHEMA.ORG FAQPAGE JSON-LD ENABLED

Is YI stock a Buy, Hold, or Sell right now according to Roarable's RQD model?

How does YI compare to PETS and RDGT in the Consumer Staples sector?

What are the biggest fundamental strengths and SEC risk factors for YI?

Where is YI trading relative to its 50-day, 200-day, and 52-week technical levels?

YI last traded at $2.92 (+2.46% on volume of 3,066 shares), positioning the stock -11.25% below its 50-day simple moving average ($3.29) and -41.95% below its 200-day simple moving average ($5.03). Across its 52-week range of $2.48 to $11.17, YI sits at the 5.1% percentile with a 14-day RSI of 36.5 (NEUTRAL RANGE) and an implied next-earnings move of ±9.2% ($2.65 to $3.19).

Direct Sub-Reports: YI RQD Cockpit YI 12M Forecast YI Earnings & Move YI Dividends & DRIP YI Insiders & 13F YI Whale Options YI Profit Sankey YI News & Why

ROARABLE RATING BRIEF • RQD 37/100 (D-) ✓ SEC XBRL & RQD VERIFIED

YI — 111 Inc.: What the Facts Mean to a Prospective Investor

Methodology: RQD v6.2 Deterministic 5-Pillar & SEC XBRL Audit

Updated: 2025-12-31

1. Roarable Rating Brief: What This Means to a Prospective Investor

111 Inc. (YI) earns a live Roarable RQD composite score of 37/100, corresponding to a D- letter grade (Roarable Sell) at a spot price of $2.92 (+2.46% 1D, market capitalization $25.1M).

Fundamental Cash Engine (9/20): Anchored by return on invested capital (ROIC) of -20.5%, gross margin of 5.8%, operating margin of 0.0%, and free cash flow yield of —.
Whale 13F & Options Flow (3/20) + Insider Conviction (5/20): Tracks institutional 13F accumulation, CBOE options call/put positioning, and SEC Form 4 / Congressional PTR filings.
Macro Regime Fit (8/20) + Forensic Balance Sheet (12/20): Incorporates a 1.00x equity beta, Altman Z-Score of 3.34, Piotroski F-Score of 3/9, and Debt/Equity of N/A.

2. Business Model, Unit Margins & SEC Financial Trajectory

. (YI) is a NASDAQ-listed issuer in the Consumer Staples sector, specifically the Retail-Drug Stores and Proprietary Stores industry. The profile does not describe its products, customers, or revenue model. The company reported revenue of $1.80B for FY 2025. Gross margin is listed as 5.8% in the market data, with operating and net margins at 0%.

In its latest audited SEC EDGAR 10-K filing for FY2025 (filed 2025-12-31), 111 Inc. (YI) reported $1.80B in annual revenue (up from $1.97B in FY2024, -9.0% YoY) and $0 in GAAP net income. Over the multi-year SEC filing window from FY2023 ($2.11B revenue, $0 net income) through FY2025, YI scaled operating cash flow to $17.0M and free cash flow to $16.4M, backed by $314.6M in total assets against $0 in total debt.

3. Institutional Bull vs. Bear Thesis & Valuation Tradeoff

🐂 Primary Bull Case (D- • RQD 37/100): Established market leader in Consumer Staples with deep daily trading liquidity. Free cash flow yield of — and institutional whale pillar of 3/20. With Fundamental Cash Engine at 9/20 and Institutional Whale Flow at 3/20, sustained execution supports upside toward the upper end of the $2.48 – $11.17 52-week range.
🐻 Primary Bear Case & Valuation Risk: Company executives have done more routine share selling than personal cash buying lately. Investors must weigh current valuation against 0.0% operating margins and a 1.00x macro beta.

4. 2nd-Order Butterfly Ripples & Key Questions to Watch

Operating in Retail-Drug Stores and Proprietary Stores (Consumer Staples), YI carries a macro regime beta of 1.00 and gross margin of 5.8%.

Key Question #1: Can YI sustain or expand its 0.0% operating margin and -20.5% ROIC against Retail-Drug Stores and Proprietary Stores peers over the next 4 quarters?
Key Question #2: Following FY2025 revenue of $1.80B and free cash flow of $16.4M, how will capital allocation balance growth reinvestment against $0 in total debt?
Key Question #3: How sensitive is YI's equity valuation to Consumer Staples capital spending cycles and macro interest-rate shifts (Beta 1.00x)?

YI Live News Feed, Press Releases & Catalyst Wire

Real-time company headlines, analyst actions, and sector developments for 111 Inc. (YI) • Click "Debate This Headline" to argue it in the Roar Pit below

💬 Jump to YI Debate Forum (3) ↓

🟡 MARKET WIRE TradingView • 1d ago

111, Inc. Estimates – NASDAQ:YI

TradingView report covering 111 Inc. (YI) market action, institutional positioning, and fundamental catalysts.

Read Full Source ↗

🟡 MARKET WIRE Yahoo Finance • 1d ago

111, Inc. Announces Appointment of Independent Financial Advisor and Legal Counsel to the Special Committee

Yahoo Finance report covering 111 Inc. (YI) market action, institutional positioning, and fundamental catalysts.

Read Full Source ↗

🟡 MARKET WIRE ad-hoc-news.de • 1d ago

111 forms special committee and reviews strategic options for 111 stock

ad-hoc-news.de report covering 111 Inc. (YI) market action, institutional positioning, and fundamental catalysts.

Read Full Source ↗

🟡 MARKET WIRE www.siam.in • 1d ago

American (YI) Advances +2.42% as Buying Pressure Builds 2026-10-18 - Elliott Wave Entry

www.siam.in report covering 111 Inc. (YI) market action, institutional positioning, and fundamental catalysts.

Read Full Source ↗

🟡 MARKET WIRE ad-hoc-news.de • 1d ago

111 forms special committee to review buyout proposal for 111 stock

ad-hoc-news.de report covering 111 Inc. (YI) market action, institutional positioning, and fundamental catalysts.

Read Full Source ↗

🟡 MARKET WIRE Yahoo Finance • 36d ago

111, Inc. Announces Establishment of the Special Committee

111, Inc. ( "111" or the "Company") (NASDAQ: YI), a leading tech-enabled healthcare platform company in China, announced today that the special committee (the "Special Committee"), comprising of three independent directo

Read Full Source ↗

🟡 MARKET WIRE Yahoo Finance • 47d ago

111 Inc. Receives Unsolicited Preliminary Non-Binding Proposal to Acquire the Company

111 Inc. ( "111" or the "Company") (NASDAQ: YI), a leading tech-enabled healthcare platform company in China, today announced that its Board of Directors (the "Board") has received an unsolicited preliminary non-binding

Read Full Source ↗

🟡 MARKET WIRE Yahoo Finance • 144d ago

Asian Equities Traded in the US as American Depositary Receipts Rise in Friday Trading, Marginally Lower for Week

Asian equities traded in the US as American depositary receipts were tracking higher Friday morning,

Read Full Source ↗

🔥 THE ROAR PIT • LIVE COMMUNITY DEBATE 3 Active Posts & Replies

YI Bull vs. Bear Conversation Board — What's Your Call at $2.92?

🐂 67% BULLISH CONVICTION COMMUNITY TUG-OF-WAR ON YI 🐻 33% BEARISH CONVICTION

CA CashFlowKing RQD DEBATE OPENER • FCF Compounder Hunter 🐂 BULLISH 🎯 Target: $3.42 (+20.0%)

📌 Pinned Debate

A special committee has been formed to review a buyout proposal, which may point to a strategic transaction.

Long YI at $2.85 targeting $3.42. A special committee has been formed to review a buyout proposal, which may point to a strategic transaction.. Institutional whale score is 3/20 and the risk/reward vs. the $2.48 52-week low is skewed heavily in favor of bulls.

RetailWhale_TX 🐂 BULL

Both sides have a point here — YI's 12/20 balance sheet score keeps downside contained, so the real swing factor next earnings call is backlog and FCF conversion.

FA FadeTheHype RQD DEBATE OPENER • Contrarian Tape Reader 🐻 BEARISH 🎯 Target: $2.45 (-14.0%)

Spot @ $2.85

Negative ROIC of -20.5% and zero FCF yield indicate the operating business is not generating returns on capital.

I respect the product at 111 Inc., but the stock at $2.85 is a different story. Negative ROIC of -20.5% and zero FCF yield indicate the operating business is not generating returns on capital.. FCF yield is 0.0% and RQD sits at 37/100 (D-) — why pay up here when you can wait for next quarter's numbers?